Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Portugal

Coordination and Support Action · Running

SAFE-HD Transforming Haemodialysis Safety with a Graphene Light-Activated Antimicrobial Device

Coordinator
GO Antimicrobial Technologies, Lda, Portugal
Runs
1 August 2026 to 31 July 2028
Status
Running
EU funding
€500k
Total cost
—
Partners
1 organisations in 1 countries
Type
Coordination and Support Action
Grant agreement
101308798

What the project is doing

In the project's own words, from its summary on CORDIS.

Catheter-related infections remain one of the most serious and costly complications in haemodialysis, affecting nearly 17.5% of catheterised patients each year and causing up to 15% mortality. Despite strict aseptic protocols and use of single-use catheter caps, infection rates continue to increase. Current approaches are inherently reactive, chemical- and antibiotic-dependent, fuelling antimicrobial resistance and generating significant medical waste.

The clinical and economic toll is severe, costing European healthcare systems over €1.7 billion every year. The GOcap®, developed by GOTECH Antimicrobial, introduces a paradigm shift in infection prevention. It is the first reusable, light-activated, graphene-based catheter cap that delivers continuous, antibiotic- and chemical-free antimicrobial action directly inside the catheter hub, the primary site of infection. Upon activation by near-infrared (NIR) light, graphene oxide (GO) generates a photothermal and photodynamic effect that destroys 99% of bacteria and fungi, including multidrug-resistant strains, without affecting patient tissues.

The device is self-contained, automated, and reusable for at least six months, reducing consumables, cost, and waste while improving patient safety and sustainability. SAFE-HD project will advance GOcap® from TRL4 to TRL6 through miniaturisation, design lock, and GLP-compliant validation, supported by ISO 13485-certified partners and clinical private and public dialysis collaborators (e.g. Diaverum, CHUSJ). Regulatory preparation (CE/FDA), quality management implementation, and market-readiness activities will ensure a clear and scalable pathway to market.

SAFE-HD will deliver a high-impact MedTech innovation: a new class of reusable, graphene-based antimicrobial devices that directly advance EU priorities on healthcare resilience and sustainability, driven by GOTECH’s multidisciplinary expertise in biomedical engineering, antimicrobial materials, and business.

Topics

Who is involved

OrganisationCityCountryRole
GO Antimicrobial Technologies, LdaPortoPortugalCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS